09:10     TEDA BIOMEDICAL<08189> - Quarterly Results Announcement (1)         

                                                                              
    Tianjin TEDA Biomedical Engineering Company Limited announced on          
    11/05/2005:                                                               
    (stock code: 08189 )                                                      
                                                                              
    Year end date                         :31/12/2005                         
    Currency                              :RMB                                
    Auditors' report                      :N/A                                
    1st Quarterly Report Reviewed by      :Audit Committee                    
                                                                              
    Important Note :                                                          
                                                                              
    This result announcement form only contains extracted information from    
    and should be read in conjunction with the detailed results announcement  
    of the issuer, which can be viewed on the GEM website at                  
    http://www.hkgem.com                                                      
                                                                              
                                               (Unaudited)       (Unaudited)  
                                                  Current Last Corresponding  
                                                   Period            Period   
                                           from 01/01/2005   from 01/01/2004  
                                             to 31/03/2005     to 31/03/2004  
                                                   RMB'000           RMB'000  
                                                                              
    Turnover                              :         17,110            12,565  
    Profit/(Loss) from Operations         :         (3,227)           (4,620) 
    Finance cost                          :           (825)             (671) 
    Share of Profit/(Loss) of Associates  :            N/A               N/A  
    Share of Profit/(Loss) of Jointly                                         
             Controlled Entites           :            N/A               N/A  
    Profit/(Loss) after Taxation & MI     :         (3,963)           (4,918) 
    % Change Over the Last Period         :            N/A                    
    EPS / (LPS)                                                               
              Basic (in dollar)           :   RMB (0.00991)      RMB (0.0123) 
              Diluted (in dollar)         :            N/A               N/A  
    Extraordinary (ETD) Gain/(Loss)       :            N/A               N/A  
    Profit (Loss) after ETD Items         :         (3,963)           (4,918) 
    1st Quarter Dividends per Share       :            NIL               NIL  
    (specify if with other options)       :            N/A               N/A  
    B/C Dates for 1st Quarter Dividends   :            N/A                    
    Payable Date                          :            N/A                    
    B/C Dates for (-) General Meeting     :            N/A                    
    Other Distribution for Current Period :            NIL                    
    B/C Dates for Other Distribution      :            N/A                    
                                           (bdi: both days inclusive)         
                                                                              
    For and on behalf of                                                      
    Tianjin TEDA Biomedical Engineering Company Limited                       
                                                                              
    Signature :                                                               
    Name      : Edmund Yip                                                    
    Title     : Company Secretary                                             
                                                                              
    Responsibility statement                                                  
                                                                              
    The directors of the Company (the "Directors") as at the date hereof      
    hereby collectively and individually accept full responsibility for the   
    accuracy of the information contained in this results announcement form   
    (the "Information") and confirm, having made all reasonable inquiries,    
    that to the best of their knowledge and belief the Information are        
    accurate and complete in all material respects and not misleading and     
    that there are no other matters the omission of which would make the      
    Information herein inaccurate or misleading.The Directors acknowledge     
    that the Stock Exchange has no responsibility whatsoever with regard to   
    the Information and undertake to indemnify the Exchange against all       
    liability incurred and all losses suffered by the Exchange in connection  
    with or relating to the Information.                                      
                                                                              
    Remarks:                                                                  
                                                                              
    1. Basis of presentation                                                  
                                                                              
    The accounts have been prepared on a going concern basis, assuming that   
    the Group will continue to operate as a going concern, notwithstanding    
    the fact that the Group suffered a net loss of RMB3,963,018 in the        
    current period resulting in accumulated loss of RMB77,993,235 as at       
    31 March 2005. The validity of the Group's ability to continue as a       
    going concern depends on the success of the Group's future operations     
    and the ability of the Group to renew or replace the banking facilities   
    as they fall due. The Group's principal banker has confirmed its          
    intention to extend and commit banking facility of up to RMB100 million   
    to the Company. As at 31 March 2005, about RMB31 million of these         
    facilities still remain unused. Consequently, the Directors have          
    prepared the unaudited quarterly results for the three months ended 31    
    March 2005 on the going concern basis.